Takeda Pharmaceutical Company Limited
TREATMENT OF CNS CONDITIONS

Last updated:

Abstract:

Aspects of the present invention relate to a method of treating an epileptic encephalopathy in a mammal in need thereof, comprising administering a composition comprising an effective amount of (4-benzyl-4-hydroxypiperidin-1-yl) (2,4'-bipyridin-3-yl)methanone or a pharmaceutically acceptable salt thereof to the mammal.

Status:
Application
Type:

Utility

Filling date:

30 Aug 2018

Issue date:

1 Oct 2020